72210-18-5

Usage

Uses

Used in Pharmaceutical Industry:
4-(2-Amino-ethoxy)-phenylamine is used as an intermediate in the production of pharmaceuticals for its role in the synthesis of various medicinal compounds.
Used in Dye and Pigment Industry:
4-(2-Amino-ethoxy)-phenylamine is used as a key component in the production of dyes and pigments, contributing to the development of colorants for different applications.
Used in Agricultural Chemicals:
4-(2-Amino-ethoxy)-phenylamine is also utilized as an intermediate in the production of agricultural chemicals, playing a part in creating substances that aid in crop protection and enhancement.
Safety Precautions:
It is important to handle 4-(2-Amino-ethoxy)-phenylamine with care as it can be a skin and eye irritant, and can be harmful if inhaled or ingested in large quantities. Proper safety measures should be taken during its use and storage to minimize potential health risks.

Upstream product

• 107-09-5 2-bromoethylamine 
• 39684-80-5 2-(tert-butoxycarbonylamino)ethyl bromide 
• 123-30-8 4-amino-phenol 
• 60814-16-6 4-Nitrophenyl 2-aminoethyl ether 
• 350-46-9 4-Fluoronitrobenzene 
• 159184-13-1 1-(2-Azidoethoxy)-4-nitrobenzene 
• 13288-06-7 1-(2-bromoethoxy)-4-nitrobenzene 

Downstream Products

• 1567434-07-4 C₂₅H₂₀FN₅O₃ 
• 1567436-01-4 C₁₃H₁₄FN₃O 
• 1613189-32-4 C₄₀H₅₀N₄O₄Si 
• 860032-83-3 5-[(R)-2-(2-{4-[4-(2-amino-ethoxy)-phenylamino]-phenyl}-ethylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one 
• 1204475-32-0 N-(2-(4-aminophenoxy)ethyl)-3,5-dinitrobenzamide 

Relevant academic research and scientific papers

PROBES FOR RAPID AND SPECIFIC DETECTION OF MYCOBACTERIA

The compositions of the present disclosure provide novel fluorogenic probes for use in the specific imaging and detection of mycobacteria species, and in particular β-lactam- antibiotic resistant. Specificity for mycobacteria is conferred on these probes

Discovery of TD-4306, a long-acting β2-agonist for the treatment of asthma and COPD

A multivalent approach focused on amine-based secondary binding groups was applied to the discovery of long-acting inhaled β2-agonists. Addition of amine moieties to the neutral secondary binding group of an existing β2-agonist serie

Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors

We designed a series of anilino-indoylmaleimides based on structural elements from literature JAK3 inhibitors 3 and 4, and our lead 5. These new compounds were tested as inhibitors of JAKs 1, 2 and 3 and TYK2 for therapeutic intervention in rheumatoid art